Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). (Q34742742)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). |
scientific article |
Statements
1 reference
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). (English)
1 reference
Carsten Bokemeyer
1 reference
Joerg Schubert
1 reference
Marita Ziepert
1 reference
Rudolf Schmits
1 reference
Martin Mohren
1 reference
Eva Lengfelder
1 reference
Marcel Reiser
1 reference
Christina Nickenig
1 reference
Michael Clemens
1 reference
Norma Peter
1 reference
Hartmut Eimermacher
1 reference
Anthony Ho
1 reference
Martin Hoffmann
1 reference
Roland Mertelsmann
1 reference
Leopold Balleisen
1 reference
Ruediger Liersch
1 reference
Bernd Metzner
1 reference
Frank Hartmann
1 reference
Bertram Glass
1 reference
Viola Poeschel
1 reference
Norbert Schmitz
1 reference
Christian Ruebe
1 reference
Alfred C Feller
1 reference
Markus Loeffler
1 reference
German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
1 reference
15 January 2008
1 reference
1 reference
Identifiers
1 reference